title: [Development of subcutaneous nodules after mesotherapy].
authors: Servicio de Medicina Interna, Unidad de Infecciosas, Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid, Majadahonda, Red Española para la Investigación de la Patología Infecciosa, Madrid, Spain. aramos220@gmail.com
authors: Antonio
authors: A
authors: Ramos
authors: Gastón
authors: G
authors: Roustan
authors: José Luis
authors: JL
authors: Lucena
authors: Rosa María
authors: RM
authors: Daza
mesh_terms: D000038:Abscess / Q000209:etiology*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D017577:Cutaneous Fistula / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D057748:Mesotherapy / Q000009:adverse effects*; D000077266:Moxifloxacin; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission*; D016926:Mycobacterium chelonae / Q000187:drug effects / Q000302:isolation & purification*; D011804:Quinolines / Q000627:therapeutic use; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission*; D013194:Staining and Labeling; D040521:Subcutaneous Tissue / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D017291:Clarithromycin; D000077266:Moxifloxacin